Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.
Related Posts
The Impact of ICH E6(R3) on Biospecimen Management
With the EMA adopting ICH E6(R3) in July, sponsors with EU trial operations must now meet stricter regulations that directly…
Abbott Publishes New Strategies to Improve DE&I in Clinical Research as Part of Diversity in Clinical Trials Initiative
Image Credit: © BillionPhotos.com – stock.adobe.com As part of its three-year, multi-million-dollar Diversity in Clinical Trials initiative, Abbott has published…
Cambridge Researchers Develop New Machine Learning Platform to Predict Chemical Reactions
Image Credit: Adobe Stock Images/catalin In collaboration with Pfizer, researchers from the University of Cambridge have created a platform called…